celastrol has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Li, H; Qin, L; Zeng, Q; Zhang, C; Zhu, N | 1 |
| Arbab, AS; Deeb, D; Gao, X; Gautam, SC; Liu, Y | 1 |
2 other study(ies) available for celastrol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
An ultrasensitive GSH-specific fluorescent probe unveils celastrol-induced ccRCC ferroptosis.
Topics: Carcinoma; Carcinoma, Renal Cell; Ferroptosis; Fluorescent Dyes; Glutathione; Humans; Kidney Neoplasms | 2023 |
Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mitochondria; NF-kappa B; Ovarian Neoplasms; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Triterpenes | 2014 |